
Share
Philanthropic groups like Open Philanthropy walk a fine line between funding high-tech AI projects and supporting traditional medical research, questioning whether the full promise of AI justifies diverting resources from established methods.
In the quest to advance medical science and improve public health, philanthropic organizations like Open Philanthropy play a crucial role. As someone who works on funding scientific research for medical progress, I often grapple with how best to allocate resources. At Open Philanthropy, only 10% of our science funding is dedicated to AI-related projects, despite the transformative potential of this technology. This raises an important question: why not focus all our efforts on AI?
AI has the potential to revolutionize healthcare by accelerating drug discovery, improving diagnostics, and enhancing research methodologies. For instance, AI can help design new drugs more efficiently, model complex cellular dynamics, and even write code for bioinformatics. These advancements are crucial because they can lead to faster and more cost-effective solutions to some of the world's most pressing health issues.
However, while AI holds great promise, it is not a panacea. The future is inherently unpredictable, and many critical areas of medical research remain essential despite the rise of AI. For example, traditional methods in vaccine development, disease prevention, and public health interventions continue to be vital. Neglected diseases that receive little attention from commercial entities still require funding and innovation.
Drug Design: AI can significantly speed up the process of identifying potential drug candidates. By analyzing vast datasets and simulating molecular interactions, AI can predict which compounds are most likely to be effective against specific diseases. This has already shown promise in areas like Alzheimer's research, where finding a cure has eluded scientists for decades.
Cell Dynamics Modeling: Understanding how cells function and interact is crucial for developing new treatments. AI can create detailed virtual models of cellular processes, allowing researchers to simulate experiments and gain insights that would be difficult or impossible with traditional methods.
Bioinformatics Code Writing: The field of bioinformatics involves analyzing large biological datasets. AI can help write and optimize the code needed to process these datasets efficiently, making it easier for researchers to extract meaningful information.

Microscopy Improvement: AI is being used to enhance microscopy techniques, such as cryo-electron microscopy, which allows scientists to visualize molecules at an atomic level. This improvement can lead to better understanding of disease mechanisms and the development of targeted therapies.
Mobile Diagnostics: With the rise of mobile technology, AI-powered diagnostics are becoming more accessible. Smartphones equipped with AI algorithms can perform tests that previously required a clinic visit, making healthcare more convenient and affordable for patients.
Publication Fraud Detection: Ensuring the integrity of scientific research is crucial. AI can help detect fraud in publications and datasets by analyzing patterns and inconsistencies, maintaining the trustworthiness of scientific findings.
Regulatory Submissions: The process of submitting new drugs and devices for regulatory approval can be complex and time-consuming. AI can assist in drafting and reviewing these submissions, streamlining the process and potentially bringing new treatments to market faster.
While AI offers exciting possibilities, it is essential to maintain a balanced approach to funding medical research. Traditional methods have proven their worth over decades and continue to address critical health issues. By allocating only 10% of our science funding to AI, we ensure that we are not neglecting other important areas of research.
AI has the potential to drive significant progress in healthcare, but it is one tool among many. By continuing to fund a diverse range of scientific projects, including those that may be less glamorous but equally important, we can make the most effective use of our resources and achieve meaningful medical advancements.
Tags
Original Sources
↗ https://blog.jacobtrefethen.com/ai-san-francisco/?utm_source=tldrai
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
5 August 2025
88 articles
Related Articles
Related Articles
More Stories